Bisoprolol Fumarate and Hydrochlorothiazide
- Product NDC
- 70518-3207
- 11-digit product format
- 705183207
- Labeler code
- 70518
- Product ID
- 70518-3207_cac91cda-a28f-0e2b-e053-2995a90aee48
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bisoprolol fumarate and hydrochlorothiazide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA075768
- Marketing category
- ANDA
- Marketing start
- 2021-08-30
- Marketing end
- 0000-00-00
- Substance
- BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
- Active strength
- 10 mg/1; mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3207-0 | 70518320700 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3207-0) | 2021-08-30 | 0000-00-00 | No | No | Current |